(Q37346201)

19 August 2017

1 reference

title

Epigenetics and dermatological disease (English)

1 reference

19 August 2017

1 reference

George W M Millington

series ordinal

1

1 reference

19 August 2017

publication date

1 December 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

9

1 reference

19 August 2017

issue

12

1 reference

19 August 2017

page(s)

1835-1850

1 reference

A metabolic throttle regulates the epigenetic state of rDNA.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

The commonality of plasticity underlying multipotent tumor cells and embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Epigenetic differences arise during the lifetime of monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

The DNA methyltransferases of mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Epigenetic events in mammalian germ-cell development: reprogramming and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

DNA methylation landscapes: provocative insights from epigenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Chromatin proteomics and epigenetic regulatory circuits.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

RNAs as extracellular signaling molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Transient cyclical methylation of promoter DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Cyclical DNA methylation of a transcriptionally active promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

MicroRNAs: novel regulators in skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Genomic imprinting and dermatological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Sexual dimorphism in non-Mendelian inheritance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Epigenetics of cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

The structural basis of protein acetylation by the p300/CBP transcriptional coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

An epigenetic vaccine model active in the prevention and treatment of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

microRNAs exhibit high frequency genomic alterations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Characterization of microRNA expression levels and their biological correlates in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Reactive oxygen species in melanoma and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Photophysical properties of 5-methylcytidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Cytosine methylation determines hot spots of DNA damage in the human P53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

TP53 mutations in human skin cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Basal cell carcinoma: biology, morphology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Time trends and familial risks in squamous cell carcinoma of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Dose-dependence, sex- and tissue-specificity, and persistence of radiation-induced genomic DNA methylation changes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

DNA adduct 8-hydroxyl-2'-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Hyperoxia-induced DNA damage causes decreased DNA methylation in human lung epithelial-like A549 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Toxicogenomics of arsenic: classical ideas and recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Long term low-dose arsenic exposure induces loss of DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Correlations between the Sonic Hedgehog pathway and basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Nonrandom karyotypic features in basal cell carcinomas of the skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Downregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Fhit is a physiological target of the protein kinase Src

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Two cases of squamous cell carcinoma treated with topical imiquimod 5%.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Relation between smoking and skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

The genetics of skin cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Toward a molecular classification of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Epigenetic control of the S100A6 (calcyclin) gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Frequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Incidence of noncutaneous melanomas in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Management of familial melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

How to make a melanoma: what do we know of the primary clonal events?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Transforming growth factor-beta activation promotes genetic context-dependent invasion of immortalized melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

High frequency of BRAF mutations in nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Distinct sets of genetic alterations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

MC1R variants increase risk of melanomas harboring BRAF mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

High BRAF mutation frequency does not characterize all melanocytic tumor types.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

No Evidence for BRAF as a melanoma/nevus susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Reprogramming of a melanoma genome by nuclear transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Frequent p16-independent inactivation of p14ARF in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Genetic and epigenetic alterations of the APC gene in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Mitf regulation of Dia1 controls melanoma proliferation and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Changes in miRNA expression in solid tumors: an miRNA profiling in melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Induction of DNA hypomethylation by tumor hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Overexpression of Akt converts radial growth melanoma to vertical growth melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

The significance of human telomerase reverse transcriptase (hTERT) in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Anthropometric measures and risk of cutaneous malignant melanoma: a case???control study from Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Case-control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Obesity and cancer risk among white and black United States veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Relation of body mass index to cancer risk in 362,552 Swedish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Epidemiology of malignant melanoma: pigmentary traits, ultraviolet radiation, and the identification of high-risk populations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

A protective effect of the Mediterranean diet for cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Mycosis fungoides and Sézary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Cutaneous T-cell lymphoma with HTLV-I infection: clinical overlap with adult T-cell leukemia/lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

The fundamental role of epigenetics in hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and sezary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

p73 supports cellular growth through c-Jun-dependent AP-1 transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Mismatch repair: mechanisms and relationship to cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

A revised estimate of twin concordance in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Demethylation of CD40LG on the inactive X in T cells from women with lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Common variants within MECP2 confer risk of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

The molecular basis for the lack of immunostimulatory activity of vertebrate DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Synthetic oligonucleotides as modulators of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Genetic factors in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Autoimmunity to nucleosomes related to viral infection: a focus on hapten-carrier complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Psoriasis and its management

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Psoriasis in Australian twins.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

p16 expression in psoriatic lesions following therapy with propylthiouracil, an antithyroid thioureylene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Scratching the surface: towards understanding the pathogenesis of atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Expression of DNMT-1 in patients with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Basal cell carcinoma: a dermatopathological and molecular biological update

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Growth retardation versus overgrowth: Silver-Russell syndrome is genetically opposite to Beckwith-Wiedemann syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Clinical effectiveness of decitabine in severe sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Selective HAT inhibitors as mechanistic tools for protein acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Valproic acid induces apoptosis, p16INK4A upregulation and sensitization to chemotherapy in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Molecularly targeted therapy for melanoma: current reality and future options

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

Array-Based Comparative Genomic Hybridization Analysis Reveals Recurrent Chromosomal Alterations and Prognostic Parameters in Primary Cutaneous Large B-Cell Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.12.1835

10.2217/14622416.9.12.1835

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference